-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $6.5

Benzinga·07/07/2026 17:19:02
Listen to the news
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $8 to $6.5.